What's Behind Bristol Myers Squibb's Latest Partnership?

What's Behind Bristol Myers Squibb's Latest Partnership?

Submitted by admin on January 22, 2022 - 2:16pm
Source: 
Motley Fool
News Tags: 
Bristol Myers Squibb
Century Therapeutics
CAR-T
cancer
Headline: 
What's Behind Bristol Myers Squibb's Latest Partnership?
snippet: 
  • Bristol Myers Squibb is licensing four off-the-shelf CAR-T cancer programs from Century Therapeutics.
  • Century will receive $100 million up front plus a $50 million equity investment from the pharmaceutical giant.
  • The deal appears to be a good one for both parties.

Do Not Allow Advertisers to Use My Personal information